Hu Yuxuan, Wang Yuqi, Wen Xidan, Pan Yifan, Cheng Xiaoyang, An Ruibing, Gao Guandao, Chen Hong-Yuan, Ye Deju
State Key Laboratory of Analytical Chemistry for Life Science, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.
State Key Laboratory of Pollution Control and Resource Reuse, School of Environment, Nanjing University, Nanjing 210023, China.
Research (Wash D C). 2020 Aug 28;2020:4087069. doi: 10.34133/2020/4087069. eCollection 2020.
Noninvasive in vivo imaging of hepatic glutathione (GSH) levels is essential to early diagnosis and prognosis of acute hepatitis. Although GSH-responsive fluorescence imaging probes have been reported for evaluation of hepatitis conditions, the low penetration depth of light in liver tissue has impeded reliable GSH visualization in the human liver. We present a liver-targeted and GSH-responsive trimodal probe (GdNPs-Gal) for rapid evaluation of lipopolysaccharide- (LPS-) induced acute liver inflammation via noninvasive, real-time in vivo imaging of hepatic GSH depletion. GdNPs-Gal are formed by molecular coassembly of a GSH-responsive Gd(III)-based MRI probe (1-Gd) and a liver-targeted probe (1-Gal) at a mole ratio of 5/1 (1-Gd/1-Gal), which shows high relaxivity with low fluorescence and fluorine magnetic resonance spectroscopic (F-MRS) signals. Upon interaction with GSH, 1-Gd and 1-Gal are cleaved and GdNPs-Gal rapidly disassemble into small molecules 2-Gd, 2-Gal, and 3, producing a substantial decline in relaxivity with compensatory enhancements in fluorescence and F-MRS. By combining in vivo magnetic resonance imaging (H-MRI) with ex vivo fluorescence imaging and F-MRS analysis, GdNPs-Gal efficiently detect hepatic GSH using three independent modalities. We noninvasively visualized LPS-induced liver inflammation and longitudinally monitored its remediation in mice after treatment with an anti-inflammatory drug, dexamethasone (DEX). Findings highlight the potential of GdNPs-Gal for in vivo imaging of liver inflammation by integrating molecular coassembly with GSH-driven disassembly, which can be applied to other responsive molecular probes for improved in vivo imaging.
肝脏谷胱甘肽(GSH)水平的无创体内成像对于急性肝炎的早期诊断和预后至关重要。尽管已经报道了用于评估肝炎状况的GSH响应荧光成像探针,但光在肝组织中的穿透深度较低,阻碍了在人体肝脏中可靠地可视化GSH。我们提出了一种肝脏靶向且GSH响应的三模态探针(GdNPs-Gal),用于通过对肝脏GSH消耗进行无创、实时体内成像来快速评估脂多糖(LPS)诱导的急性肝脏炎症。GdNPs-Gal由基于GSH响应的Gd(III)磁共振成像(MRI)探针(1-Gd)和肝脏靶向探针(1-Gal)以5/1(1-Gd/1-Gal)的摩尔比进行分子共组装形成,其显示出高弛豫率以及低荧光和氟磁共振波谱(F-MRS)信号。与GSH相互作用时,1-Gd和1-Gal被裂解,GdNPs-Gal迅速分解为小分子2-Gd、2-Gal和3,导致弛豫率大幅下降,同时荧光和F-MRS得到补偿增强。通过将体内磁共振成像(H-MRI)与离体荧光成像和F-MRS分析相结合,GdNPs-Gal利用三种独立的模态有效地检测肝脏GSH。我们通过无创方式可视化了LPS诱导的肝脏炎症,并在用抗炎药地塞米松(DEX)治疗后对小鼠体内炎症的修复过程进行了纵向监测。研究结果突出了GdNPs-Gal通过整合分子共组装与GSH驱动的分解用于肝脏炎症体内成像的潜力,这可应用于其他响应性分子探针以改善体内成像。